The July 27, 2014 Focus On Rhabdo Webinar with Dr. Janet Shipley talking about a double pronged strategy that uses two experimental cancer drugs together is now available to view on the web. Dr Shipley explains that a combination of drugs could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment. Dr. Shipley’s research team at The Institute of Cancer Research, London, found that combining two separate molecularly targeted therapies could stop processes driving growth in a cancer called rhabdomyosarcoma, a major cause of cancer death in children. Further lab work/pre-clinical testing will be required before progression to clinical testing.
To View the Presentation Click Here
You need to be logged onto the website to view the presentation. Registration at Focus On Rhabdo is free to all.